Clinical Trial Update: Pramipexole in Untreated and Levodopa-treated Parkinson's Disease Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating pramipexole in untreated and levodopa-treated Parkinson's disease patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Mirapex (pramipexole)
• Pramipexole (pramipexole)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Parkinson Disease | Phase 3 | Status: COMPLETED